Discussions of self-referral rarely present new information, but they can lead to self-interest accusations and more.
On a physicians’ online forum I frequent, self-referral came up again. It’s been rehashed to the extent that one might consider the topic pureed by now. New points rarely, if ever, seem to be made. So when people start in on it again, I always assume there’s potential new legislation on the matter. Everybody then wants to make sure that the world hears about how self-referral is a Very Bad Thing…or, alternatively, that it’s No Big Deal.
The ensuing flurry of words usually contains a mixture of passion, hope, despair, stridence, bitterness, venom, and, occasionally, common sense or (*gasp*) objective logic. One might think, being somewhat scientific sorts, doctors would value and focus more heavily on the latter elements. The problem with this is that sometimes one’s opponent has a better debate-game on the subject and/or is armed with irksome tools like academic studies supporting his position.
Happily, one need not compete on equal footing. The all-purpose rebuttal: Accusations of self-interest. To appear academic, as well, suggest that the opposition’s reference sources are biased. The fun part of this is that you’re not quite calling your opponent and his colleagues liars and fraudsters, out to line their pockets by any nefarious means. Thus, if they take offense, they’re being the unreasonable ones.
Another enjoyable aspect of this approach is that it takes all the workload out of what could otherwise be an effortful debate. While the other guy is offering up multiple lines of reasoning and evidence in support of his position, you can just keep on poking him with the oblique insinuation that his arguments are based on self-interest and therefore-ta da!-devoid of merit. You have probably encountered individuals who use similar “debate” tactics in other environments:
A: I offer line of reasoning #1 in support of my position.
B: I counter with line of reasoning #2.
A: I add line #3 to my argument.
B: I insist on #2.
A: Um…well, I also have #4.
B: Fine. I still say #2.
A: [Clenching teeth a bit] I further put forward #5-12.
B: #2 beats all of those.
A: [Walks away in frustration/disgust]
B: Yaay! I win! Everyone saw that, right?
One might suggest that, as opposing camps in the self-referral wars each have items of self-interest at stake, it makes sense to consider them mutually nullified, permitting everyone to move on with more substantive aspects of the debate. This seems fair and efficient to everybody except the individuals whose “argument” contained little aside from accusations of self-interest. For instance, a clinician wanting to defend self-referral with the support of a single neurologist-penned paper would rather not match it up against a radiologist who is backed by half a dozen studies identifying self-referral’s downsides (some put forth by the Congressional Budget Office itself).
Perhaps to prevent being thusly checkmated, they’ll unabashedly claim that their self-interest is less in quantity or baseness than that of their opponents…or, with just as much claimed holiness-of-cause, deny any self-interest at all. At which point their self-importance becomes quite evident….
Burnout in Radiology: Key Risk Factors and Promising Solutions
June 9th 2025Recognizing the daunting combination of increasing imaging volume and workforce shortages, these authors discuss key risk factors contributing to burnout and moral injury in radiology, and potential solutions to help preserve well-being among radiologists.
Mammography AI Platform for Five-Year Breast Cancer Risk Prediction Gets FDA De Novo Authorization
June 2nd 2025Through AI recognition of subtle patterns in breast tissue on screening mammograms, the Clairity Breast software reportedly provides validated risk scoring for predicting one’s five-year risk of breast cancer.
The Reading Room: Artificial Intelligence: What RSNA 2020 Offered, and What 2021 Could Bring
December 5th 2020Nina Kottler, M.D., chief medical officer of AI at Radiology Partners, discusses, during RSNA 2020, what new developments the annual meeting provided about these technologies, sessions to access, and what to expect in the coming year.
Can Emerging AI Software Offer Detection of CAD on CCTA on Par with Radiologists?
May 14th 2025In a study involving over 1,000 patients who had coronary computed tomography angiography (CCTA) exams, AI software demonstrated a 90 percent AUC for assessments of cases > CAD-RADS 3 and 4A and had a 98 percent NPV for obstructive coronary artery disease.
Could AI-Powered Abbreviated MRI Reinvent Detection for Structural Abnormalities of the Knee?
April 24th 2025Employing deep learning image reconstruction, parallel imaging and multi-slice acceleration in a sub-five-minute 3T knee MRI, researchers noted 100 percent sensitivity and 99 percent specificity for anterior cruciate ligament (ACL) tears.